Fluorine-containing drugs approved by the FDA in 2019

Haibo Mei, Attila Márió Remete, Yupiao Zou, Hiroki Moriwaki, Santos Fustero, Lorand Kiss, Vadim A. Soloshonok, Jianlin Han

PDF(1567 KB)
　

Search
Submit
E-mail
RSS
Chinese Chemical Letters ›› 2020, Vol. 31 ›› Issue (09) : 2401-2413. DOI: 10.1016/j.cclet.2020.03.050
Reviews

Fluorine-containing drugs approved by the FDA in 2019

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 31(09): 2401-2413 https://doi.org/10.1016/j.cclet.2020.03.050

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1567 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Editorial Office of Chinese Chemical Letters
Address: 1 Xian Nong Tan Street, Xicheng District, Beijing, China　Zip code: 100050
Phone: 86-10-63165638　Email: cclbj@imm.ac.cn

/

〈 〉